You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biliary Tract Neoplasms

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul

Not yet recruiting
  • HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Feb 19, 2023

Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

Not yet recruiting
  • Locally Advanced Biliary Tract Cancer
  • Metastatic Biliary Tract Cancer
  • Camrelizumab and Apatinib Plus GP
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Feb 15, 2023

Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)

Recruiting
  • Resectable Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Nov 30, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Jun 8, 2022

Multi-Platform Profiling of Resected Biliary Tract Cancer

Recruiting
  • Biliary Tract Cancer
  • +7 more
  • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
  • Chicago, Illinois
  • +1 more
Jan 23, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • nab-paclitaxel plus gemcitabine-cisplatin
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Oct 27, 2022

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)

Recruiting
  • Biliary Tract Cancer
  • Changchun, Jilin, China
    Liu Bo
Aug 18, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

UCAD for Diagnosing Benign or Malignant Biliary Obstruction and

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • The level of CIN
  • Shanghai, Shanghai, China
    Xinhua Hospital
Jan 12, 2023

Pancreas Cancer Trial (mRNA expression)

Not yet recruiting
  • Pancreas Cancer
  • mRNA expression
  • (no location specified)
Aug 8, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

    Not yet recruiting
    • Biliary Tract Cancer
    • +3 more
    • (no location specified)
    Aug 16, 2022

    Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Durvalumab
    • +5 more
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

    Recruiting
    • Advanced Biliary Tract Cancer
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-sen University
    Oct 11, 2022

    Bile Duct Stricture, Endoscopic Retrograde Cholangiopancreatography, Biliary Disease Trial in Beijing (Transparent cap)

    Recruiting
    • Bile Duct Stricture
    • +3 more
    • Transparent cap
    • Beijing, Beijing, China
      The Fifth Medical Center of Chinese PLA General Hosptial
    Apr 14, 2022

    Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

    Withdrawn
    • Platinum-Sensitive Biliary Tract Cancer
    • (no location specified)
    May 27, 2022

    Biliary Obstruction, Pancreatic Cancer, Biliary Tract Tumors Trial in L'Hospitalet de Llobregat (Double pigtail plastic stent

    Active, not recruiting
    • Biliary Obstruction
    • +2 more
    • Double pigtail plastic stent through lumen-apposing metal stent
    • Lumen-apposing metal stent without double pigtail plastic stent
    • L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    • +1 more
    Dec 28, 2022

    Biliary Tract Cancer Trial in Boston, Ann Arbor, Nashville (Rucaparib, Nivolumab)

    Active, not recruiting
    • Biliary Tract Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 6, 2022

    Biliary Tract Cancer Trial (RC48-ADC, Envafolimab)

    Not yet recruiting
    • Biliary Tract Cancer
    • (no location specified)
    Jun 9, 2022

    Biliary Carcinoma Trial in Nanjing (Disitamab Vedotin combined with Zimberelizumab)

    Recruiting
    • Biliary Carcinoma
    • Disitamab Vedotin combined with Zimberelizumab
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Sep 14, 2022

    Hepatic Tumors, Biliary Tract Tumors, Pancreatic Tumors Trial in Seoul (Perioperative rehabilitation program, Conventional)

    Completed
    • Hepatic Neoplasms
    • +2 more
    • Perioperative rehabilitation program
    • Conventional
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Nov 16, 2022

    Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

    Active, not recruiting
    Has Results
    • Cholangiocarcinoma
    • +6 more
    • Laboratory Biomarker Analysis
    • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
    • Scottsdale, Arizona
    • +1 more
    Jan 4, 2023

    Gastrointestinal Cancer Trial in Hangzhou (Pemigatinib Pill)

    Recruiting
    • Gastrointestinal Cancer
    • Pemigatinib Pill
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 26, 2022